Page last updated: 2024-08-17

mepenzolate bromide and Centriacinar Emphysema

mepenzolate bromide has been researched along with Centriacinar Emphysema in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, T; Fukunishi, Y; Kanda, Y; Kawahara, M; Mizushima, T; Takafuji, A; Takenaga, M; Tanaka, KI; Yamakawa, N; Yamashita, Y1

Other Studies

1 other study(ies) available for mepenzolate bromide and Centriacinar Emphysema

ArticleYear
Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.
    Bioorganic & medicinal chemistry, 2019, 08-01, Volume: 27, Issue:15

    Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzilates; Bronchodilator Agents; Dose-Response Relationship, Drug; Mice; Molecular Structure; Pancreatic Elastase; Piperidines; Pulmonary Emphysema; Receptor, Muscarinic M3; Structure-Activity Relationship; Swine

2019